Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Nivalis Therapeutics (United States) | Researchclopedia

Back to institutions

Nivalis Therapeutics (United States)

Boulder, Coloradocompany

185

Works

36,549

Citations

103

h-index

Top Research Topics

Advanced biosensing and bioanalysis techniques RNA and protein synthesis mechanisms DNA and Nucleic Acid Chemistry

Top Researchers

Ajit Varki University of Basel

759 works65,872 citationsh-index: 130

Recent Research

Motor Function and Growth Outcomes With Early Corticosteroid Initiation in Duchenne Muscular Dystrophy: An Adjusted Cross‐Trial Comparison

Emma Ciafaloni,Abigail Zion,et al.

20260 citations

RNA Interference and Gene Delivery

Monoclonal and Polyclonal Antibodies Research

RNA modifications and cancer

Nitric Oxide and Endothelin Effects

Cell Adhesion Molecules Research

Bacteriophages and microbial interactions

RNA Research and Splicing

Chemical Synthesis and Analysis

Eicosanoids and Hypertension Pharmacology

Alan J. Korman Bristol-Myers Squibb (Germany)

384 works50,957 citationsh-index: 72

Larry Gold The University of Notre Dame Australia

186 works30,085 citationsh-index: 68

James E. Smith Southern Research Institute

966 works28,370 citationsh-index: 72

Elizabeth A. Kellogg Harvard University

423 works23,528 citationsh-index: 82

Qi Wang Hebei Medical University

975 works23,206 citationsh-index: 64

Six Sigma Optimized Lipid-based Delivery System for Ibuprofen: Enhanced Solubility, Robust Process Control, and Bioequivalence

Rachana Patel,Gayatri Patel,et al.

20250 citations

Preliminary safety and efficacy of ELVN-001, a selective active site inhibitor of BCR::ABL1, in patients with CML driven by atypical fusion transcripts

Andreas Hochhaus,Susanne Saußele,et al.

20251 citations

Updated efficacy and safety results of JNJ-5322, a novel, next-generation BCMA×GPRC5D×CD3 trispecific antibody, in patients with Relapsed/Refractory multiple myeloma

Amrita Krishnan,Martin Kaiser,et al.

20250 citations

Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study

Ajai Chari,Niels W.C.J. van de Donk,et al.

20258 citations

629PTrajectory of north star ambulatory assessment with sevasemten compares favorably to natural history modeling in Becker muscular dystrophy

E. Niks,J. Signorovitch,et al.

20250 citations